Ubs Asset Management Americas Inc Biomea Fusion, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 35,429 shares of BMEA stock, worth $350,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,429
Previous 11,600
205.42%
Holding current value
$350,747
Previous $173,000
8.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BMEA
# of Institutions
120Shares Held
17.9MCall Options Held
978KPut Options Held
286K-
Cormorant Asset Management, LP Boston, MA3.57MShares$35.4 Million1.24% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$23.2 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$20.9 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$13.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.1MShares$10.9 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $290M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...